We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+11.22%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.92B
AUM Growth
-$861M
Cap. Flow
-$1.08B
Cap. Flow %
-56.34%
Top 10 Hldgs %
24.9%
Holding
1,961
New
419
Increased
272
Reduced
381
Closed
669

Sector Composition

Rank Sector Weight
1 Financials 17.05%
2 Technology 12.34%
3 Consumer Discretionary 8.56%
4 Industrials 7.99%
5 Healthcare 7.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IBOC icon
401
International Bancshares
IBOC
$4.57B
$927K 0.05%
20,268
-18,342
-48% -$883K
AEYE icon
402
AudioEye
AEYE
$75M
$922K 0.05%
240,856
+32,809
+16% +$163K
SBS icon
403
Sabesp
SBS
$18.7B
$922K 0.05%
445,859
+312,388
+234% +$660K
OHI icon
404
PUT
Omega Healthcare
OHI
$14.7B
$920K 0.05%
+32,900
New +$992K
AR icon
405
Antero Resources
AR
$10.7B
$915K 0.05%
29,524
-1,189
-4% -$41.1K
BIL icon
406
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
$46.7B
$915K 0.05%
+10,000
New +$915K
HZNP
407
CALL
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$910K 0.05%
+8,000
New +$664K
KSS icon
408
Kohl's
KSS
$2.19B
$908K 0.05%
35,973
-3,400
-9% -$96.4K
SLCA
409
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
$904K 0.05%
72,288
-3,114
-4% -$39.9K
IRM icon
410
PUT
Iron Mountain
IRM
$36.1B
$902K 0.05%
+18,100
New +$914K
ADNT icon
411
Adient
ADNT
$1.5B
$902K 0.05%
+26,003
New +$909K
TRTX
412
TPG RE Finance Trust
TRTX
$618M
$898K 0.05%
132,201
-18,105
-12% -$134K
ASND icon
413
Ascendis Pharma A/S
ASND
$16.8B
$892K 0.05%
7,300
+2,300
+46% +$267K
MAG
414
DELISTED
MAG Silver
MAG
$873K 0.05%
55,842
-826
-1% -$12K
MPT
415
PUT
Medical Properties Trust
MPT
$2.81B
$860K 0.04%
+77,200
New +$898K
GOGN
416
DELISTED
GoGreen Investments Corporation
GOGN
$856K 0.04%
82,502
MLCO icon
417
Melco Resorts & Entertainment
MLCO
$2.14B
$840K 0.04%
73,032
+5,121
+8% +$41.6K
ARGX icon
418
argenx
ARGX
$54.1B
$837K 0.04%
2,210
+399
+22% +$149K
VNQ icon
419
PUT
Vanguard Real Estate ETF
VNQ
$39.1B
$833K 0.04%
+10,100
New +$837K
AXNX
420
DELISTED
Axonics, Inc. Common Stock
AXNX
$828K 0.04%
13,249
+4,116
+45% +$273K
UNH icon
421
UnitedHealth
UNH
$370B
$819K 0.04%
1,544
-2,145
-58% -$1.14M
TWLV
422
DELISTED
Twelve Seas Investment Company II Class A Common Stock
TWLV
$806K 0.04%
+80,200
New +$797K
AESC
423
DELISTED
The AES Corporation
AESC
$805K 0.04%
7,892
+1,334
+20% +$131K
BLEU
424
DELISTED
bleuacacia ltd Class A Ordinary Shares
BLEU
$805K 0.04%
80,000
-43,235
-35% -$431K
QQQ icon
425
CALL
Invesco QQQ Trust
QQQ
$481B
$799K 0.04%
3,000
-35,900
-92% -$9.93M

Similar funds

Prelude Capital Management's Q4 2022 Portfolio in Review

As of Q4 2022, Prelude Capital Management held 1,961 positions worth $1.92B, down 31% from $2.79B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Prelude Capital Management withdrew a net $1.08B in Q4 2022, closing 669 positions and reducing 381 holdings. Its most notable exit was KKR Acquisition Holdings I Corp., an estimated $30.7M position sold in full.

By sector, the portfolio is most concentrated in Financials at 17% of assets, down from 18% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Prelude Capital Management opened a new position in AVEO Pharmaceuticals, Inc. worth $7.55M.

  • Prelude Capital Management's largest Q4 2022 buy was AVEO Pharmaceuticals, Inc.: 504,972 shares worth $7.55M.
  • Prelude Capital Management added most to KE Holdings in Q4 2022, an estimated $13.6M increase.
  • Prelude Capital Management's biggest Q4 2022 reduction was Alphabet (Google) Class A, cutting an estimated $6.9M.
  • Prelude Capital Management fully exited KKR Acquisition Holdings I Corp. in Q4 2022, selling an estimated $30.7M.
  • Prelude Capital Management's ten largest holdings make up 25% of its $1.92B portfolio in Q4 2022.
  • Prelude Capital Management opened 419 new positions and closed 669 in Q4 2022.
  • Prelude Capital Management's portfolio value fell 31% quarter-over-quarter to $1.92B.

Based on Prelude Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.